nicotinamide riboside (Niagen) — Topline data
in 2026
Data analysis is underway and the data from this phase 3 trial is expected to be published in 2026.Source filing
NIAGEN BIOSCIENCE INC · Data as of 2026-09-08
in 2026
Data analysis is underway and the data from this phase 3 trial is expected to be published in 2026.Source filing